Oncology Institute (TOIIW) Capital Expenditures (2021 - 2026)

Oncology Institute (TOIIW) has 6 years of Capital Expenditures data on file, last reported at $1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 217.68% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 11.61% YoY), and the FY2025 full-year result was $3.2 million, down 15.54% from the prior year.
• Capital Expenditures for Q1 2026 stood at $1.0 million, down from $1.1 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $1.8 million in Q1 2023 and bottomed at -$3.5 million in Q4 2022.
• The 5-year median for Capital Expenditures is $1.0 million (2022), against an average of $741058.8.
• The widest annual swing landed in 2022, when Capital Expenditures plunged 505.74%; it then jumped 250.25% in 2025.
• A 5-year view of Capital Expenditures shows it stood at -$3.5 million in 2022, then surged by 124.36% to $861000.0 in 2023, then surged by 103.83% to $1.8 million in 2024, then plunged by 39.6% to $1.1 million in 2025, then retreated by 1.7% to $1.0 million in 2026.
• The last three Capital Expenditures figures came in at $1.0 million (Q1 2026), $1.1 million (Q4 2025), and $604000.0 (Q3 2025), per Business Quant data.

Peer Comparison